Invest Qatar has concluded a high-level roadshow across New York and Boston in the US, strengthening engagement with leading US investors, businesses and industry stakeholders while showcasing Qatar’s growing investment opportunities across technology, biotechnology, life sciences and healthcare.
The roadshow forms part of Invest Qatar’s continued efforts to deepen economic ties with the United States and build long-term partnerships with businesses and investors seeking opportunities in Qatar.
The programme was anchored by Invest Qatar’s participation as an official partner of the Qatar Economic Forum: UNGA Special Edition 2026, held in New York on September 20, alongside targeted B2B meetings, networking engagements and a high-level roundtable hosted jointly with DLA Piper.
Across the two cities, Invest Qatar engaged with leading US companies and investors to highlight the country’s competitive business environment, advanced infrastructure, innovation ecosystem and opportunities across high-growth sectors.
The delegation met with Arbor Biotech, a next-generation gene-editing company focused on discovering and developing potentially curative genomic medicines; Alloy Therapeutics, a biotechnology ecosystem company supporting drug discovery and development through AI-driven platforms and integrated services; Entech, a global provider of software, systems integration and resource management solutions; and Enveda, a biotechnology company combining AI, metabolomics and automated laboratory technologies to accelerate drug discovery.
Invest Qatar also participated in a high-level roundtable organised by DLA Piper, a global law firm with lawyers located in more than 40 countries. The event brought together leading investors, industry experts and high-growth companies across financial technology (Fintech), artificial intelligence (AI), health technology (Healthtech) and cybersecurity.
The discussion highlighted Qatar’s investment proposition and explored opportunities for international expansion, market entry and strategic investment across Qatar and the region.
Marking the occasion, Fahad Al Kuwari, Chief Investment Development Officer at Invest Qatar, said: “Our engagement across New York and Boston reflects our commitment to building long-term relationships with investors and businesses that share our ambition to accelerate innovation and support sustainable growth in technology, biotechnology, life sciences and healthcare. Qatar offers an attractive platform for companies looking to establish or expand their operations and access opportunities across the region, supported by advanced infrastructure, a strong research ecosystem, a business-friendly environment and a clear national vision for economic diversification.”
Through initiatives such as this roadshow, we are connecting global businesses with the opportunities, partnerships and capabilities that Qatar offers.
